← SynDRA
PF-00562271
SynDRA canonical compound SYN0022234 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PTK2 |
|---|
| Mechanism of action | Focal adhesion kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- FAK inhibitor
- PTK2 INHIBITOR
- Focal adhesion kinase 1 inhibitor
- AURKA INHIBITOR
- FLT3 INHIBITOR
- PTK2B INHIBITOR
Cross-references
Synonyms
- Pf-562271 besilate
- PF 00562271-26
- PF 562271
- PF-562271
- PF-00562271 free base
- PF-562271 free base
- PF562271
- PF-562,271
- K5BX8ZA7UF
- RefChem:172289
- DTXCID20208905
- C21H20F3N7O3S
- MFCD16038299
- PF562271 besylate;PF 562271 besylate
- PF-562271 BESILATE
- Kinome_3857
- 3bz3
- UNII-K5BX8ZA7UF
- MLS006011245
- GTPL9381
- orb1305448
- SCHEMBL1206959
- SCHEMBL29381854
- SCHEMBL29637167
- CHEBI:91370
- MZDKLVOWGIOKTN-UHFFFAOYSA-N
- GLXC-90235
- HMS3244K07
- HMS3244K08
- HMS3244L07
- HMS3265M11
- HMS3265M12
- HMS3265N11
- HMS3265N12
- HMS3651D06
- EX-A1385
- BDBM50318884
- NSC754356
Look up PF-00562271 in the interactive SynDRA portal →